PAKOLA STEVE bought RGNX

July 1, 2026 · Form 4 insider transaction

PAKOLA STEVE bought 36,725 shares of REGENXBIO Inc. at $7.86 per share, a transaction worth $288.7K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Acquired (buy-side)
Shares
36,725
Price
$7.86
Total value
$288.7K
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 1, 2026
Filing dateJuly 1, 2026
Shares owned after249,734
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan.

View the original Form 4 on SEC EDGAR